Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2024

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at the 24th Annual Biotech in Europe Forum

Posted on September 23, 2024 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that CEO John Climaco will present at the 24th Annual Biotech in … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Partnership with Staque to Accelerate Commercial Adoption of Quantum in the Middle East

Posted on September 23, 2024 by MissionIR

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, has announced its partnership with Staque, a leading consulting and development practice with a focus on … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating ‘More Effective, Tolerable’ Oral Delivery of GLP-1 Drugs

Posted on September 20, 2024 by MissionIR

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, looks to offer a better alternative to diabetes management and treatment through its patented DehydraTECH(TM) technology. “Lexaria has recently made strides with glucagon-like peptide-1 (‘GLP-1’) studies. It has … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Stands Distinct from Industry Players with Buntanetap

Posted on September 20, 2024 by MissionIR

Annovis Bio (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, secured U.S. patent No. 12,042,482 covering methods for treating traumatic brain injury (“TBI”) and nerve injury with buntanetap, the company’s lead drug candidate. “Buntanetap (formerly … Continue reading →

Posted in Annovis Bio Inc. ANVS | Leave a comment

MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Inks Licensing Agreement to Use Bitrex(R) Aversive Agent for Flagship Product

Posted on September 20, 2024 by MissionIR

Nutriband (NASDAQ: NTRB), a company engaged in the development of prescription transdermal pharmaceutical products, has signed a trademark licensing agreement for the use of Bitrex(R) brand denatonium benzoate. According to the announcement, Bitrex is the most bitter substance in the … Continue reading →

Posted in Nutriband Inc. NTRB, Small Cap News | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Joins Chicago Quantum Exchange to Help Advance Quantum Science and Commercialization

Posted on September 20, 2024 by MissionIR

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has joined the Chicago Quantum Exchange (“CQE”), a leading quantum research hub connecting academia, industry and national labs. … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

Domestic Violence Victim Data Breach is a Case Example Showing Critical Need for Monitoring Technology of SuperCom Ltd. (NASDAQ: SPCB)

Posted on September 20, 2024 by MissionIR

Electronic monitoring (“EM”) technology innovator SuperCom (NASDAQ: SPCB) has built its PureSecurity suite as a public safety solution that draws on the most advanced technology to track the movements of potentially dangerous individuals who nevertheless are deemed a low enough … Continue reading →

Posted in SuperCom Ltd. SPCB | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires New CEO Amid Shift in Focus to Pharmaceutical Industry Collaboration and Operations

Posted on September 20, 2024 by MissionIR

Lexaria (NASDAQ: LEXX), a global innovator in drug delivery platforms, has, since 2016, worked on the development of its patented DehydraTECH(TM) technology. It has repeatedly demonstrated the ability to increase bio-absorption and has also evidenced an ability to deliver some … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Hosting First-Ever Qubits Event in UAE

Posted on September 19, 2024 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, is organizing the first Qubits quantum computing event in the United Arab Emirates. According to a company announcement, the … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

Newest SuperCom Ltd. (NASDAQ: SPCB) Contracts Worth $2.6 Million Show Strength of European Electronic Monitoring (‘EM’) Market

Posted on September 18, 2024 by MissionIR

The Confederation of European Probation, an organization that promotes pan-European cooperation for the social inclusion of offenders through a variety of community sanctions, reports high-tech electronic monitoring services are booming throughout Europe as a security solution benefitting both the offenders … Continue reading →

Posted in SuperCom Ltd. SPCB | Leave a comment